No Data
Jiangsu Apon Medical Technology (300753.SZ): The company has officially joined the "brain-computer interface industry alliance" as one of its members.
Jiangsu Apon Medical Technology (300753.SZ) stated on the investor interaction platform on November 4th that it will participate in the second Brain-Computer Interface Conference and the fourth Brain-Computer Interface Industry Alliance General Meeting, scheduled to be held in Wuhan, Hubei on November 16th to 17th. The company has been invited to attend. The company has officially joined the "Brain-Computer Interface Industry Alliance" as one of its members. This conference, themed "Brain-Computer Interconnection, Co-creating the Future", aims to enhance the exchange and cooperation between brain-computer interface technology and industry, discussing the future development of the brain-computer interface industry.
Aibang Healthcare: Third Quarter 2024 Report
Jiangsu Apon Medical Technology (300753.SZ): Net income in the first three quarters was 3.8073 million yuan, a decrease of 43.99% year-on-year.
Gelonghui October 29th | Jiangsu Apon Medical Technology (300753.SZ) announced its third quarter report for 2024, with the company achieving revenue of 0.275 billion yuan in the first three quarters of the year, a decrease of 7.12% year-on-year; net income attributable to the shareholders of the listed company was 3.8073 million yuan, a decrease of 43.99% year-on-year; net income attributable to the shareholders of the listed company excluding non-recurring gains and losses was 0.8721 million yuan, a decrease of 74.25% year-on-year; basic earnings per share were 0.0302 yuan.
Jiangsu Apon Medical Technology (300753.SZ): Currently, it has achieved new functions in the field of depth of anesthesia algorithm by implementing techniques such as EEG time-frequency analysis and intraoperative brain aging assessment based on intraoper
Jiangsu Apon Medical Technology (300753.SZ) stated on the investor interaction platform that the brain-computer interface system is mainly composed of the user (brain), brain signal acquisition, brain signal processing, external device control, and neural feedback. The company's anesthesia depth monitor product belongs to the brainwave acquisition equipment, using non-invasive electrodes to acquire EEG signals for application in the field of anesthesia depth monitoring. Currently, the company has implemented new functions in brainwave anesthesia depth algorithms, such as brainwave time-frequency analysis technology and brain aging assessment based on intraoperative brainwave characteristics.
Apon Medical Technology's Parent to Divest 5.6% of Company for 76 Million Yuan
Express News | Jiangsu Apon Medical Technology: The controlling shareholder intends to transfer 5.6% of the shares.
No Data
No Data